Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 0.48 |
| ▸ | HRH1 | P35367 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.47 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.46 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | CCR5 | P51681 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL171013 | 1.00 | HTR2A (0.48) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| SCHEMBL8926699 | 1.00 | HTR2A (0.48) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| Hydrochloric Acid SCHEMBL235622 | 0.98 | TDP1 (0.50) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| Hydrochloric Acid SCHEMBL18378384 | 0.98 | TDP1 (0.50) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| Bromide SCHEMBL4071099 | 0.98 | HTR2A (0.46) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| Iodide SCHEMBL10962372 | 0.98 | HTR2A (0.46) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| Hydrochloric Acid SCHEMBL14762879 | 0.98 | TDP1 (0.50) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| Water SCHEMBL27613449 | 0.98 | HTR2A (0.46) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| Hydrochloric Acid SCHEMBL8067968 | 0.96 | TDP1 (0.48) | HTR2AHRH1LMNACHRNB2CHRNB4 | |
| Hydrochloric Acid SCHEMBL28230488 | 0.96 | TDP1 (0.48) | HTR2AHRH1LMNACHRNB2CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3783089-B1 | ANTIMICROBIAL COMPOSITION COMPRISING ALKYLATED POLYVINYLPYRROLIDONE POLYMER | PROCTER & GAMBLE (US) | 2023-08-23 | — | — | EP | claimed |
| EP-3561036-B1 | HARD SURFACE CLEANERS COMPRISING CARBOXYLATED FRUCTAN | PROCTER & GAMBLE (US) | 2023-08-09 | — | — | EP | claimed |
| EP-3852608-A1 | COMPOSITIONS AND METHODS FOR GLAUCOMA | Aufbau Medical Innovations Limited (IE) | 2021-07-28 | — | — | EP | claimed |
| WO-2020061550-A1 | COMPOSITIONS AND METHODS FOR GLAUCOMA | AUFBAU MEDICAL INNOVATIONS LIMITED (IE) | 2020-03-26 | — | — | WO | claimed |
| CN-103396320-A | (S)-3-chloro-N, N-dimethyl-1-phenyl-1-propylamine and method for preparing dapoxetine by using same as intermediate | NANJING HAIRONG PHARMACEUTICAL TECHNOLOGY CO LTD | 2013-11-20 | — | — | CN | claimed |
| EP-2424514-A1 | USE OF 1-PHENYL-3-DIMETHYLAMINOPROPANE COMPOUNDS FOR TREATING RHEUMATOID PAIN | Grünenthal GmbH (DE) | 2012-03-07 | — | — | EP | claimed |
| WO-2011092719-A2 | PROCESS FOR THE PREPARATION OF L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVES | IND-SWIFT LABORATORIES LIMITED (IN) | 2011-08-04 | — | — | WO | claimed |
| WO-2011080756-A1 | PROCESS FOR THE PREPARATION OF 1-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVES | IND-SWIFT LABORATORIES LIMITED (IN) | 2011-07-07 | — | — | WO | claimed |
| WO-2010124856-A1 | USE OF 1-PHENYL-3-DIMETHYLAMINOPROPANE COMPOUNDS FOR TREATING RHEUMATOID PAIN | Grünenthal GmbH (DE) | 2010-11-04 | — | — | WO | claimed |
| CN-100421654-C | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence | GRUENENTHAL GMBH (DE) | 2008-10-01 | — | — | CN | claimed |
| EP-1408941-B1 | USE OF A PHARMACEUTICAL COMPOSITION COMPRISING TWO QUATERNARY AMMONIUM COMPOUNDS AND AN ORGANOMETALLIC ONE IN THE TREATMENT OF VIRAL AND FUNGAL INFECTIONS AND DISEASES | ZETETIC RES INC (US) | 2007-05-09 | — | — | EP | claimed |
| CN-1622803-A | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence | GRUENENTHAL GMBH (DE) | 2005-06-01 | — | — | CN | claimed |
| US-6492445-B2 | DERIVED FROM EMULSION POLYMERIZATION OF ETHYLENICALLY UNSATURATED SULFONIC, PHOSPHORIC AND/OR CARBOXYLIC ACIDS, AND SUBSTANTIALLY SATURATED ANTIMICROBIAL QUATERNARY AMMONIUM COMPOUNDS; PROLONGED ANTIMICROBIAL ACTIVITY | STEPAN COMPANY | 2002-12-10 | — | — | US | claimed |
| US-20020040092-A1 | Antimicrobial polymer latexes derived from unsaturated quaternary ammonium compounds and antimicrobial coatings, sealant, adhesives and elastomers produced from such latexes | STEPAN COMPANY | 2002-04-04 | — | — | US | claimed |
| EP-1105429-A1 | ANTIMICROBIAL POLYMER LATEXES DERIVED FROM UNSATURATED QUATERNARY AMMONIUM COMPOUNDS AND ANTIMICROBIAL COATINGS, SEALANTS, ADHESIVES AND ELASTOMERS PRODUCED FROM SUCH LATEXES | STEPAN COMPANY (US) | 2001-06-13 | — | — | EP | claimed |
| US-6242526-B1 | MONOMER UNIT IS DERIVED FROM AN ETHYLENICALLY UNSATURATED MONOMER AND THE SURFACE ACTIVE AGENT UNIT IS DERIVED FROM A POLYMERIZABLE ANTIBACTERIAL QUATERNARY AMMONIUM COMPOUND. | STEPAN COMPANY | 2001-06-05 | — | — | US | claimed |
| WO-2000006612-A1 | ANTIMICROBIAL POLYMER LATEXES DERIVED FROM UNSATURATED QUATERNARY AMMONIUM COMPOUNDS AND ANTIMICROBIAL COATINGS, SEALANTS, ADHESIVES AND ELASTOMERS PRODUCED FROM SUCH LATEXES | STEPAN COMPANY (US) | 2000-02-10 | — | — | WO | claimed |
| EP-0034126-B1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS FOR SHAVING THE SKIN | Maggesi, Luigi (IT) | 1984-07-04 | — | — | EP | claimed |
| US-20250024837-A1 | PESTICIDE SYSTEM | BANISH, MICHELE | 2025-01-23 | — | — | US | disclosed |
| US-3932655-A | CHELATING AGENTS, N-ALKYL BENZALKONIUM CHLORIDES | INTERNATIONAL PHARMAKON LABORATORIES, INC. (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250024837-A1 | PESTICIDE SYSTEM | ACHE, PFAS, FPGS | HTR2A 936/4885HRH1 3583/4885LMNA 3099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.